Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | CASR | P41180 | 3/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 4/20 | 0.44 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9684114 | 0.75 | CYP2D6 (0.51) | CYP2D6MAPTADRB2ADRB1ADRB3 | |
| Benzamide SCHEMBL4775810 | 0.74 | HIF1A (0.58) | PARP10ALDH1A1ABCB1 | |
| SCHEMBL9812104 | 0.73 | CYP2D6 (0.51) | CYP2D6MAPTCASRADRB2ADRB1 | |
| SCHEMBL9362874 | 0.73 | CYP2D6 (0.56) | CYP2D6MAPTCASRADRB2ADRB1 | |
| SCHEMBL9685173 | 0.71 | ADRB1 (0.69) | ADRB2ADRB1ADRB3 | |
| SCHEMBL9685167 | 0.71 | ADRB1 (0.69) | ADRB2ADRB1ADRB3 | |
| SCHEMBL9330171 | 0.71 | CYP2D6 (0.58) | CYP2D6MAPTCASRADRB2ADRB1 | |
| SCHEMBL10822357 | 0.71 | BCAT2 (0.48) | MAPTADRB1ADRB3ALDH1A1 | |
| SCHEMBL11373388 | 0.70 | CYP2D6 (0.77) | CYP2D6MAPTCASRADRB2ADRB1 | |
| SCHEMBL9683304 | 0.70 | MEN1 (0.76) | CYP2D6ADRB2ADRB1ADRB3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5166218-A | Antilipemic agents or antiglycemic agents | HOFFMANN-LA ROCHE INC. (US) | 1992-11-24 | — | — | US | disclosed |
| US-5064863-A | Catabolic activity, obesity, diabetes | HOFFMANN-LA ROCHE INC. (US) | 1991-11-12 | — | — | US | disclosed |
| EP-0140243-A2 | Phenoxypropanol amines | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1985-05-08 | — | — | EP | disclosed |